InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,064.20
(
0.91%
)
US TECH 100
17,190.00
(
0.67%
)
Dow Jones
38,225.66
(
0.85%
)
Brent Oil
83.87
(
0.28%
)
Bitcoin
59,033.95
(
-0.15%
)
Post# of 251694
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119554
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: north40000 post# 213736

Wednesday, 09/20/2017 10:38:09 AM

Wednesday, September 20, 2017 10:38:09 AM

Post# of 251694

Is the real problem that PCPs are reluctant to switch patients from a long prescribed product.../

That's an impediment to the uptake of FoBs for chronic diseases, but it's not the main impediment, IMO. Rather, the main impediment is the subject of PFE's lawsuit: the branded-drug companies' use of exclusionary contracts with PBMs and third-party payers to try to shut FoBs out of the market.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up